The domestic market registered a growth of nearly 12 per cent in 2012. This year in March, IMS had projected a growth of around 12 per cent, but later in September, revised it downwards to 10 per cent.

The domestic pharma industry, which is generally recession-proof and has traditionally registered a strong double-digit clip over the years, is now witnessing a big slowdown. With October becoming the third consecutive month to record sluggish growth, the Rs 72,000-crore pharma retail market is expected to grow by a low single digit for the year.
The phase of low growth, which started in August and worsened over the last couple of months, ..